Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Letrozole with or without aspirin in postmenopausal ER-positive breast cancer
ACTRN12614000507684Phase 2Terminated
- Sponsor
- University of Otago
- Start
- Dec 2014
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of letrozole and aspirin in breast cancer (2 arms), sponsored by University of Otago. Started Dec 2014; status: terminated.
02
Drugs
letrozoleaspirin
03
Conditions
breast cancer
Beyond the preview
Go deeper on ACTRN12614000507684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12614000507684.